Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences最新文献

筛选
英文 中文
Influencing factors of futile recanalization after endovascular intervention in patients with acute basilar artery occlusion. 急性基底动脉闭塞患者血管内介入治疗后无效再通畅的影响因素。
Yi Yan, Kemeng Zhang, Wansi Zhong, Shenqiang Yan, Bing Zhang, Jianhua Cheng, Min Lou
{"title":"Influencing factors of futile recanalization after endovascular intervention in patients with acute basilar artery occlusion.","authors":"Yi Yan, Kemeng Zhang, Wansi Zhong, Shenqiang Yan, Bing Zhang, Jianhua Cheng, Min Lou","doi":"10.3724/zdxbyxb-2023-0425","DOIUrl":"10.3724/zdxbyxb-2023-0425","url":null,"abstract":"<p><strong>Objectives: </strong>To explore the influence factors for futile recanalization following endovascular treatment (EVT) in patients with acute basilar artery occlusion (BAO).</p><p><strong>Methods: </strong>Clinical data of patients with acute BAO, who underwent endovascular treatment within 24 h of onset from January 2017 to November 2022, were retrospectively analyzed. The futile recanalization was defined as modified thrombolysis in cerebral infarction (mTICI) grade ≥2b or 3 after successful reperfusion, but the modified Rankin Scale score >2 at 3 months after EVT. Binary logistic regression model was used to analyze the influencing factors of futile recanalization.</p><p><strong>Results: </strong>A total of 471 patients with a median age of 68 (57, 74) years were included and 68.9% were males, among whom 298 (63.27%) experienced futile recanalization. Multivariate analysis revealed that concomitant atrial fibrillation (<i>OR</i>=0.456, 95%<i>CI</i>: 0.282-0.737, <i>P</i><0.01), bridging thrombolysis (<i>OR</i>=0.640, 95%<i>CI</i>: 0.416-0.985, <i>P</i><0.05), achieving mTICI grade 3 (<i>OR</i>=0.554, 95%<i>CI</i>: 0.334-0.918, <i>P</i><0.05), arterial occlusive lesion (AOL) grade 3 (<i>OR</i>=0.521, 95%<i>CI</i>: 0.326-0.834, <i>P</i><0.01), and early postoperative statin therapy (<i>OR</i>=0.509, 95%<i>CI</i>: 0.273-0.948, <i>P</i><0.05) were protective factors for futile recanalization after EVT in acute BAO patients. High baseline National Institutes of Health Stroke Scale (NIHSS) score (<i>OR</i>=1.068, 95%<i>CI</i>: 1.049-1.087, <i>P</i><0.01), coexisting hypertension (<i>OR</i>=1.571, 95%<i>CI</i>: 1.017-2.427, <i>P</i><0.05), multiple retrieval attempts (<i>OR</i>=1.237, 95%<i>CI</i>: 1.029-1.488, <i>P</i><0.05) and postoperative hemorrhagic transformation (<i>OR</i>=8.497, 95%<i>CI</i>: 2.879-25.076, <i>P</i><0.01) were risk factors. For trial of ORG 10172 in acute stroke treatment (TOAST) classification, cardiogenic embolism (<i>OR</i>=0.321, 95%<i>CI</i>: 0.193-0.534, <i>P</i><0.01) and other types (<i>OR</i>=0.499, 95%<i>CI</i>: 0.260-0.961, <i>P</i><0.05) were related to lower incidence of futile recanalization.</p><p><strong>Conclusions: </strong>The incidence of futile recanalization after EVT in patients with acute BAO is high. Bridging venous thrombolysis before operation and an early postoperative statin therapy may reduce the incidence of futile recanalization.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"141-150"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057989/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159198","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Progress on functions of intracellular domain of trimeric ligand-gated ion channels. 了解三聚配体门控离子通道中细胞内结构域的门控和功能作用的最新进展。
Yan Lu, Yiyu Lin, Jin Wang
{"title":"Progress on functions of intracellular domain <b>of</b> trimeric ligand-gated ion channels.","authors":"Yan Lu, Yiyu Lin, Jin Wang","doi":"10.3724/zdxbyxb-2023-0472","DOIUrl":"10.3724/zdxbyxb-2023-0472","url":null,"abstract":"<p><p>Ligand-gated ion channels are a large category of essential ion channels, modulating their state by binding to specific ligands to allow ions to pass through the cell membrane. Purinergic ligand-gated ion channel receptors (P2XRs) and acid-sensitive ion channels (ASICs) are representative members of trimeric ligand-gated ion channel. Recent studies have shown that structural differences in the intracellular domain of P2XRs may determine the desensitization process. The lateral fenestrations of P2XRs potentially serve as a pathway for ion conductance and play a decisive role in ion selectivity. Phosphorylation of numerous amino acid residues in the P2XRs are involved in regulating the activity of ion channels. Additionally, the P2XRs interact with other ligand-gated ion channels including <i>N</i>-methyl-<i>D</i>-aspartate receptors, γ-aminobutyric acid receptors, 5-hydroxytryptamin receptors and nicotinic acetylcholine receptors, mediating physiological processes such as synaptic plasticity. Conformational changes in the intracellular domain of the ASICs expose binding sites of intracellular signal partners, facilitating metabolic signal transduction. Amino acids such as Val16, Ser17, Ile18, Gln19 and Ala20 in the ASICs participate in channel opening and membrane expression. ASICs can also bind to intracellular proteins, such as CIPP and p11, to regulate channel function. Many phosphorylation sites at the C-terminus and N-terminus of ASICs are involved in the regulation of receptors. Furthermore, ASICs are involved in various physiological and pathophysiological processes, which include pain, ischemic stroke, psychiatric disorders, and neurodegenerative disease. In this article, we review the roles of the intracellular domains of these trimeric ligand-gated ion channels in channel gating as well as their physiological and pathological functions, in order to provide new insights into the discovery of related drugs.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"221-230"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057991/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681613","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Safety of early antiplatelet therapy for non-cardioembolic mild stroke patients with thrombocytopenia. 对血小板减少的非心栓性轻度脑卒中患者进行早期抗血小板治疗的安全性。
Dongjuan Xu, Huan Zhou, Mengmeng Hu, Yilei Shen, Hongfei Li, Lianyan Wei, Jing Xu, Zhuangzhuang Jiang, Xiaoli Shao, Zhenhua Xi, Songbin He, Min Lou, Shaofa Ke
{"title":"Safety of early antiplatelet therapy for non-cardioembolic mild stroke patients with thrombocytopenia.","authors":"Dongjuan Xu, Huan Zhou, Mengmeng Hu, Yilei Shen, Hongfei Li, Lianyan Wei, Jing Xu, Zhuangzhuang Jiang, Xiaoli Shao, Zhenhua Xi, Songbin He, Min Lou, Shaofa Ke","doi":"10.3724/zdxbyxb-2023-0423","DOIUrl":"10.3724/zdxbyxb-2023-0423","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the safety of early antiplatelet therapy for non-cardioembolic mild stroke patients with thrombocytopenia.</p><p><strong>Methods: </strong>Data of acute ischemic stroke patients with baseline National Institutes of Health Stroke Scale (NIHSS) score ≤3 and a platelet count <100×10<sup>9</sup>/L were obtained from a multicenter register. Those who required anticoagulation or had other contraindications to antiplatelet therapy were excluded. Short-term safety outcomes were in-hospital bleeding events, while the long-term safety outcome was a 1-year all-cause death. The short-term neurological outcomes were evaluated by modified Rankin scale (mRS) score at discharge.</p><p><strong>Results: </strong>A total of 1868 non-cardioembolic mild stroke patients with thrombocytopenia were enrolled. Multivariate regression analyses showed that mono-antiplatelet therapy significantly increased the proportion of mRS score of 0-1 at discharge (<i>OR</i>=1.657, 95%<i>CI</i>: 1.253-2.192, <i>P</i><0.01) and did not increase the risk of intracranial hemorrhage (<i>OR</i>=2.359, 95%<i>CI</i>: 0.301-18.503, <i>P</i>>0.05), compared with those without antiplatelet therapy. However, dual-antiplatelet therapy did not bring more neurological benefits (<i>OR</i>=0.923, 95%<i>CI</i>: 0.690-1.234, <i>P</i>>0.05), but increased the risk of gastrointestinal bleeding (<i>OR</i>=2.837, 95%<i>CI</i>: 1.311-6.136, <i>P</i><0.01) compared with those with mono-antiplatelet therapy. For patients with platelet counts ≤75×10<sup>9</sup>/L and >90×10<sup>9</sup>/L, antiplatelet therapy significantly improved neurological functional outcomes (both <i>P</i><0.05). For those with platelet counts (>75-90)×10<sup>9</sup>/L, antiplatelet therapy resulted in a significant improvement of 1-year survival (<i>P</i><0.05). For patients even with concurrent coagulation abnormalities, mono-antiplatelet therapy did not increase the risk of various types of bleeding (all <i>P</i>>0.05) but improved neurological functional outcomes (all <i>P</i><0.01). There was no significant difference in the occurrence of bleeding events, 1-year all-cause mortality risk, and neurological functional outcomes between aspirin and clopidogrel (all <i>P</i>>0.05).</p><p><strong>Conclusions: </strong>For non-cardioembolic mild stroke patients with thrombocytopenia, antiplatelet therapy remains a reasonable choice. Mono-antiplatelet therapy has the same efficiency as dual-antiplatelet therapy in neurological outcome improvement with lower risk of gastrointestinal bleeding.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"175-183"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057994/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140294775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinical and genetic analysis of essential hypertension with mitochondrial tRNAMet 4435A>G and YARS2 mutation. 线粒体 tRNAMet 4435A>G 和 YARS2 基因突变的本质性高血压临床和遗传分析
Meili Guo, Yunfan He, Ade Chen, Zaishou Zhuang, Xiaoyong Pan, Minxin Guan
{"title":"Clinical and genetic analysis of essential hypertension with mitochondrial tRNA<sup>Met</sup> 4435A>G and <i>YARS2</i> mutation.","authors":"Meili Guo, Yunfan He, Ade Chen, Zaishou Zhuang, Xiaoyong Pan, Minxin Guan","doi":"10.3724/zdxbyxb-2023-0571","DOIUrl":"10.3724/zdxbyxb-2023-0571","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the role of m.4435A>G and <i>YARS2</i> c.572G>T (p.G191V) mutations in the development of essential hypertension.</p><p><strong>Methods: </strong>A hypertensive patient with m.4435A>G and <i>YARS2</i> p.G191V mutations was identified from previously collected mitochondrial genome and exon sequencing data. Clinical data were collected, and a molecular genetic study was conducted in the proband and his family members. Peripheral venous blood was collected, and immortalized lymphocyte lines constructed. The mitochondrial transfer RNA (tRNA), mitochondrial protein, adenosine triphosphate (ATP), mitochondrial membrane potential (MMP), and reactive oxygen species (ROS) in the constructed lymphocyte cell lines were measured.</p><p><strong>Results: </strong>Mitochondrial genome sequencing showed that all maternal members carried a highly conserved m.4435A>G mutation. The m.4435A>G mutation might affect the secondary structure and folding free energy of mitochondrial tRNA and change its stability, which may influence the anticodon ring structure. Compared with the control group, the cell lines carrying m.4435A>G and <i>YARS2</i> p.G191V mutations had decreased mitochondrial tRNA homeostasis, mitochondrial protein expression, ATP production and MMP levels, as well as increased ROS levels (all <i>P</i><0.05).</p><p><strong>Conclusions: </strong>The <i>YARS2</i> p.G191V mutation aggravates the changes in mitochondrial translation and mitochondrial function caused by m.4435A>G through affecting the steady-state level of mitochondrial tRNA and further leads to cell dysfunction, indicating that <i>YARS2</i> p.G191V and m.4435A>G mutations have a synergistic effect in this family and jointly participate in the occurrence and development of essential hypertension.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"184-193"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057996/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140336974","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Association between baseline hemoglobin level and early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke. 急性缺血性脑卒中患者静脉溶栓后基线血红蛋白水平与早期神经功能恶化之间的关系。
Tinghuan Wang, Wansi Zhong, Zhicai Chen, Ke Shen, Huiya Ye, Zhihui Yu, Jia Luo, Jun Ma, Min Lou
{"title":"Association between baseline hemoglobin level and early neurological deterioration after intravenous thrombolysis in patients with acute ischemic stroke.","authors":"Tinghuan Wang, Wansi Zhong, Zhicai Chen, Ke Shen, Huiya Ye, Zhihui Yu, Jia Luo, Jun Ma, Min Lou","doi":"10.3724/zdxbyxb-2023-0510","DOIUrl":"10.3724/zdxbyxb-2023-0510","url":null,"abstract":"<p><strong>Objectives: </strong>To investigate the association between baseline hemoglobin level and early neurologic deterioration (END) after intravenous thrombolysis in patients with acute ischemic stroke (AIS).</p><p><strong>Methods: </strong>Data of AIS patients who received intravenous thrombolytic therapy at multiple hospitals across the country between January 2017 and July 2020 were collected from the online database Acute Stroke Patients for Stroke Management Quality Evaluation (CASE-Ⅱ, NCT04487340). Binary logistic regression analysis was used to study the factors affecting the occurrence of END after intravenous thrombolytic therapy, and the correlation between baseline hemoglobin level and END was investigated by limiting cubic spline curve analysis.</p><p><strong>Results: </strong>A total of 8162 patients were included. Patients with END had lower baseline hemoglobin levels (136 and 140 g/L, <i>P</i><0.01) and higher rates of anemia (24.2% and 16.9%, <i>P</i><0.01) compared with non-END patients. Binary logistic regression analysis showed that baseline hemoglobin level (<i>OR</i>=0.995, 95%<i>CI</i>: 0.991-0.999, <i>P</i><0.05) and anemia (<i>OR</i>=1.238, 95%<i>CI</i>: 1.055-1.454, <i>P</i><0.01) were independently correlated with the occurrence of END after intravenous thrombolysis in AIS patients. Restricted cubic spline regression showed that there was a U-shaped relationship between hemoglobin level and the risk of END after intravenous thrombolysis in AIS patients (<i>P</i><0.01), although this relationship was only significant in male patients (<i>P</i><0.05) and not in female patients (<i>P</i>>0.05).</p><p><strong>Conclusions: </strong>There is a correlation between baseline hemoglobin level and the risk of END in AIS patients after intravenous thrombolysis, especially in male patients, in whom both lower and higher hemoglobin level may increase the risk of END.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"168-174"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057983/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159159","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effect of anesthesia mode during endovascular treatment on neurological functional outcomes in patients with acute posterior circulation stroke. 血管内治疗期间的麻醉模式对急性后循环卒中患者神经功能预后的影响。
Xiaofeng Zhu, Zheyu Zhang, Wansi Zhong, Yaode He, Zhongyu Luo, Ningyuan Zhang, Chaochan Cheng, Jianhong Yang, Min Lou
{"title":"Effect of anesthesia mode during endovascular treatment on neurological functional outcomes in patients with acute posterior circulation stroke.","authors":"Xiaofeng Zhu, Zheyu Zhang, Wansi Zhong, Yaode He, Zhongyu Luo, Ningyuan Zhang, Chaochan Cheng, Jianhong Yang, Min Lou","doi":"10.3724/zdxbyxb-2023-0453","DOIUrl":"10.3724/zdxbyxb-2023-0453","url":null,"abstract":"<p><strong>Objectives: </strong>To compare the effect of anesthesia mode on the neurological functional outcomes in patients undergoing endovascular treatment for acute posterior circulation ischemic stroke.</p><p><strong>Methods: </strong>Clinical data of 656 patients undergoing intravascular therapy for acute posterior circulation ischemic stroke registered in online Acute Stroke Patients for Stroke Management Quality Evaluation Database from January 2017 to December 2022 were retrospectively analyzed. The data included 163 cases with conscious sedation and 493 cases with general anesthesia during the procedure. After propensity score matching, 428 patients were included in the analysis, including 155 cases in the conscious sedation group and 273 cases in the general anesthesia group. The differences of operation mode, etiology type, vascular recanalization, hemorrhagic transformation at 24 h, modified Rankin Scale (mRS) score at 3 months and mortality within 3 months were compared between the two groups. Binary logistic regression was used to explore the effect of different anesthesia mode on neurological functional outcomes.</p><p><strong>Results: </strong>There was a significant difference in operation mode between the two groups (<i>P</i><0.01), while there were no significant differences in etiology type, vascular recanalization, hemorrhagic transformation at 24 h, mRS score at 3 months or mortality within 3 months (all <i>P</i>>0.05). Binary logistic regression analysis revealed that anesthesia modes were not significantly associated with functional outcomes of patients (<i>OR</i>=1.151, 95%<i>CI</i>: 0.751-1.765, <i>P</i>>0.05).</p><p><strong>Conclusions: </strong>Anesthesia mode (conscious sedation or general anesthesia) will not affect the neurological functional outcomes in patients with acute posterior circulation ischemic stroke undergoing endovascular treatment.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"151-159"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057984/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159197","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Isolation and structural identification of a potassium ion channel Kv4.1 inhibitor SsTx-P2 from centipede venom. 从蜈蚣毒液中分离并鉴定钾离子通道 Kv4.1 抑制剂 SsTx-P2 的结构。
Canwei DU, Fuchu Yuan, Xinyi Duan, Mingqiang Rong, Er Meng, Changjun Liu
{"title":"Isolation and structural identification of a potassium ion channel Kv4.1 inhibitor SsTx-P2 from centipede venom.","authors":"Canwei DU, Fuchu Yuan, Xinyi Duan, Mingqiang Rong, Er Meng, Changjun Liu","doi":"10.3724/zdxbyxb-2023-0430","DOIUrl":"10.3724/zdxbyxb-2023-0430","url":null,"abstract":"<p><strong>Objectives: </strong>To isolate a potassium ion channel Kv4.1 inhibitor from centipede venom, and to determine its sequence and structure.</p><p><strong>Methods: </strong>Ion-exchange chromatography and reversed-phase high-performance liquid chromatography were performed to separate and purify peptide components of centipede venom, and their inhibiting effect on Kv4.1 channel was determined by whole-cell patch clamp recording. The molecular weight of isolated peptide Kv4.1 channel inhibitor was identified with matrix assisted laser desorption ionization-time-of-flight mass spectrometry; its primary sequence was determined by Edman degradation sequencing and two-dimensional mass spectrometry; its structure was established based on iterative thread assembly refinement online analysis.</p><p><strong>Results: </strong>A peptide SsTx-P2 was separated from centipede venom with the molecular weight of 6122.8, and its primary sequence consists of 53 amino acid residues NH<sub>2</sub>-ELTWDFVRTCCKLFPDKSECTKACATEFTGGDESRLKDVWPRKLRSGDSRLKD-OH. Peptide SsTx-P2 potently inhibited the current of Kv4.1 channel transiently transfected in HEK293 cell, with 1.0 μmol/L SsTx-P2 suppressing 95% current of Kv4.1 channel. Its structure showed that SsTx-P2 shared a conserved helical structure.</p><p><strong>Conclusions: </strong>The study has isolated a novel peptide SsTx-P2 from centipede venom, which can potently inhibit the potassium ion channel Kv4.1 and displays structural conservation.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"194-200"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057981/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139546617","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Design, synthesis and functional validation of peptide inhibitors based on TRPV1 ion channel agonist RhTx. 基于 TRPV1 离子通道激动剂 RhTx 的多肽抑制剂的设计、合成和功能验证。
Heng Zhang, Jiawei Wang, Fan Yang
{"title":"Design, synthesis and functional validation of peptide inhibitors based on TRPV1 ion channel agonist RhTx.","authors":"Heng Zhang, Jiawei Wang, Fan Yang","doi":"10.3724/zdxbyxb-2023-0465","DOIUrl":"10.3724/zdxbyxb-2023-0465","url":null,"abstract":"<p><strong>Objectives: </strong>To design and synthesize peptide inhibitors targeting transient receptor potential vanilloid 1 (TRPV1) ion channel, and to validate their function.</p><p><strong>Methods: </strong>Based on previous studies on the relation of molecular structure and function of red head toxin (RhTx), a series of peptides were rationally designed and synthesized, with positive charged amino acids linked to the N terminus of RhTx. These Nplus-RhTx peptides were functionally validated by patch-clamp recordings in live cells.</p><p><strong>Results: </strong>Among the 8 synthesized Nplus-RhTx peptides, four inhibited TRPV1 ion channel activated by capsaicin with IC<sub>50</sub> of (188.3±4.7), (193.6±18.0), (282.8±11.9) and (299.5±6.4) µmol/L, respectively.</p><p><strong>Conclusions: </strong>It is feasible to develop TRPV1 peptide inhibitors by using rational design based on N terminal residues of RhTx.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"201-207"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057985/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140159160","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Research progress on the pathogenesis of chest tightness variant asthma characterized by chest tightness. 以胸闷为特征的变异型哮喘发病机制研究进展。
Luanqing Che, Jianxing Lai, Huaqiong Huang, Wen Li, Huahao Shen
{"title":"Research progress on the pathogenesis of chest tightness variant asthma characterized by chest tightness.","authors":"Luanqing Che, Jianxing Lai, Huaqiong Huang, Wen Li, Huahao Shen","doi":"10.3724/zdxbyxb-2023-0442","DOIUrl":"10.3724/zdxbyxb-2023-0442","url":null,"abstract":"<p><p>Chest tightness variant asthma (CTVA) is an atypical form of asthma with chest tightness as the sole or predominant symptom. The underlying receptors for chest tightness are bronchial C-fibers or rapidly adapting receptors. The nerve impulses are transmitted via the vagus nerve and processed in different regions of the cerebral cortex. Chest tightness is associated with sensory perception, and CTVA patients may have heightened ability to detect subtle changes in lung function, but such sensory perception is unrelated to respiratory muscle activity, lung hyperinflation, or mechanical loading of the respiratory system. Airway inflammation, pulmonary ventilation dysfunction (especially involving small airways), and airway hyperresponsiveness may underlie the sensation of chest tightness. CTVA patients are prone to comorbid anxiety and depression, which share similar central nervous system processing pathways with dyspnea, suggesting a possible neurological basis for the development of CTVA. This article examines the recognition and mechanisms of chest tightness, and explores the pathogenesis of CTVA, focusing on its association with airway inflammation, ventilation dysfunction, airway hyperresponsiveness, and psychosocial factors.</p>","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" ","pages":"213-220"},"PeriodicalIF":0.0,"publicationDate":"2024-04-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11057992/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139681614","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Efficacy and safety of tetrandrine in treatment of rheumatoid arthritis: a meta analysis. 四氢化可的松治疗类风湿性关节炎的疗效和安全性:一项荟萃分析。
Juan Xu, Jichen Li, Yan Ye, Qing Zhao, Duo Lyu
{"title":"Efficacy and safety of tetrandrine in treatment of rheumatoid arthritis: a meta analysis.","authors":"Juan Xu, Jichen Li, Yan Ye, Qing Zhao, Duo Lyu","doi":"10.3724/zdxbyxb-2024-0002","DOIUrl":"https://doi.org/10.3724/zdxbyxb-2024-0002","url":null,"abstract":"OBJECTIVES\u0000To explore the efficacy and safety of tetrandrine in the treatment of rheumatoid arthritis.\u0000\u0000\u0000METHODS\u0000Randomized controlled studies of tetrandrine in the treatment of rheumatoid arthritis were searched in China National Knowledge Infrastructure (CNKI), China Science and Technology Journal Database (VIP), World Wide Web Database, SinoMed, PubMed, Springer, Web of Science, the Cochrane Central Register of Controlled Trails database. A meta-analysis was conducted using R software version 3.5.3 to evaluate the clinical outcomes, including the total effective rate, erythrocyte sedimentation rate (ESR), C-reactive protein (CRP), rheumatoid factor (RF), visual analog scale (VAS) for pain, disease activity score (DAS), tender joint count (TJC), swollen joint count (SJC), and morning stiffness duration, as well as adverse events of RA patients.\u0000\u0000\u0000RESULTS\u0000A total of 10 articles were included in the study. The meta-analysis indicated that tetrandrine significantly improved the total effective rate (OR=3.27, 95%CI: 2.01-5.37, P<0.01), ESR (SMD=1.12, 95%CI: 0.06-2.19, P<0.05), CRP (SMD=0.75, 95%CI: 0.28-1.22, P<0.01), VAS (SMD=0.55, 95%CI: 0.21-0.89, P<0.01), SJC (SMD=0.85, 95%CI: 0.40-1.31, P<0.01), TJC (SMD=1.16, 95%CI: 0.58-1.74, P<0.01), and morning stiffness (SMD=1.09, 95%CI: 0.68-1.50, P<0.01). However, no statistical significance was found in RF (SMD=1.70, 95%CI: -1.10-4.51, P>0.05) and DAS (SMD=0.26, 95%CI: -0.59-1.11, P>0.05). The overall incidence of adverse events associated with tetrandrine treatment for rheumatoid arthritis was 20% (95%CI: 12%-27%, I2=60%, P<0.05), with mild severity and favorable outcomes.\u0000\u0000\u0000CONCLUSIONS\u0000Tetrandrine is effective in the treatment of RA patients with a mild degree of adverse events.","PeriodicalId":24007,"journal":{"name":"Zhejiang da xue xue bao. Yi xue ban = Journal of Zhejiang University. Medical sciences","volume":" 11","pages":"1-9"},"PeriodicalIF":0.0,"publicationDate":"2024-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"140689538","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信